GeoVax Labs, Inc.
GOVX
$1.28
-$0.06-4.48%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 2.49M | 3.35M | 6.14M | 5.59M | 3.95M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 2.49M | 3.35M | 6.14M | 5.59M | 3.95M |
| Cost of Revenue | 18.12M | 22.74M | 25.09M | 24.64M | 23.71M |
| Gross Profit | -15.63M | -19.38M | -18.95M | -19.05M | -19.76M |
| SG&A Expenses | 6.01M | 6.16M | 6.07M | 5.62M | 5.39M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 24.13M | 28.90M | 31.17M | 30.26M | 29.10M |
| Operating Income | -21.64M | -25.54M | -25.02M | -24.67M | -25.14M |
| Income Before Tax | -21.46M | -25.31M | -24.81M | -24.50M | -24.99M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -21.46 | -25.31 | -24.81 | -24.50 | -24.99 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -21.46M | -25.31M | -24.81M | -24.50M | -24.99M |
| EBIT | -21.64M | -25.54M | -25.02M | -24.67M | -25.14M |
| EBITDA | -21.57M | -25.47M | -24.94M | -24.57M | -25.05M |
| EPS Basic | -30.28 | -49.15 | -64.06 | -105.17 | -155.75 |
| Normalized Basic EPS | -18.92 | -30.72 | -40.04 | -65.73 | -97.34 |
| EPS Diluted | -30.28 | -49.15 | -64.06 | -105.17 | -155.75 |
| Normalized Diluted EPS | -18.92 | -30.72 | -40.04 | -65.73 | -97.34 |
| Average Basic Shares Outstanding | 3.64M | 2.29M | 1.73M | 1.22M | 838.30K |
| Average Diluted Shares Outstanding | 3.64M | 2.29M | 1.73M | 1.22M | 838.30K |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |